Abstract
To avoid the accumulation of metoclopramide that occurs with repeated i.v. bolus doses, a new regimen for the administration of high-dose metoclopramide consisting of a loading dose followed by a continuous infusion was investigated to determine the pharmacokinetics and antiemetic efficacy of the drug when given in this manner. Nine patients with non-Hodgkin's lymphoma entered the study, of whom six completed the study, receiving each of three dosage schedules of metoclopramide during three consecutive courses of chemotherapy. In these six patients plasma metoclopramide half-life was 5.9 +/- 0.4 h (mean +/- s.e. mean) and plasma clearance was 25.4 +/- 4.8 l/h (mean +/- s.e. mean). Neither half-life nor clearance were dose-related. Steady-state was achieved during 9/18 infusions. Nausea and vomiting were completely controlled in 13/24 treatment courses (57%) and adverse effects were minimal. We conclude that steady-state plasma concentrations of metoclopramide can be achieved using a weight-related infusion regimen, though the optimum plasma concentration remains to be determined.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arita T., Hori R., Ito K., Ichikawa K. Transformation and excretion of drugs in biological systems. 3. Separatory determination of metoclopramide and its N4-glucuronide and N4-sulfonate in rabbit urine and bile. Chem Pharm Bull (Tokyo) 1970 Aug;18(8):1670–1674. doi: 10.1248/cpb.18.1670. [DOI] [PubMed] [Google Scholar]
- Bateman D. N., Gokal R., Dodd T. R., Blain P. G. The pharmacokinetics of single doses of metoclopramide in renal failure. Eur J Clin Pharmacol. 1981;19(6):437–441. doi: 10.1007/BF00548588. [DOI] [PubMed] [Google Scholar]
- Bateman D. N., Kahn C., Davies D. S. The pharmacokinetics of metoclopramide in man with observations in the dog. Br J Clin Pharmacol. 1980 Apr;9(4):371–377. doi: 10.1111/j.1365-2125.1980.tb01064.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graffner C., Lagerström P. O., Lundborg P., Rönn O. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography. Br J Clin Pharmacol. 1979 Nov;8(5):469–474. doi: 10.1111/j.1365-2125.1979.tb01028.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gralla R. J., Itri L. M., Pisko S. E., Squillante A. E., Kelsen D. P., Braun D. W., Jr, Bordin L. A., Braun T. J., Young C. W. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981 Oct 15;305(16):905–909. doi: 10.1056/NEJM198110153051601. [DOI] [PubMed] [Google Scholar]
- Strum S. B., McDermed J. E., Opfell R. W., Riech L. P. Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy. JAMA. 1982 May 21;247(19):2683–2686. doi: 10.1001/jama.247.19.2683. [DOI] [PubMed] [Google Scholar]
- Taylor W. D., Bateman D. N. High dose metoclopramide-preliminary pharmacokinetic studies. Br J Clin Pharmacol. 1983 Sep;16(3):341–342. doi: 10.1111/j.1365-2125.1983.tb02173.x. [DOI] [PMC free article] [PubMed] [Google Scholar]